Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc.

ATOS
Atossa Therapeutics, Inc.US flagNASDAQ Capital Market
2.40
USD
-0.09
- -
20.67MMarket Cap

Atossa Therapeutics, Inc. (ATOS) Stock Split History

Learn about Atossa Therapeutics, Inc.'s most recent 1-for-15 basis stock split on February 02, 2026. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Atossa Therapeutics, Inc.'s most recent stock split

Split Date: 2026-02-02
Split Ratio: 1:15
Price Before Split: $0.37
Price After Split: $0.02

Developer API

Get ATOS split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/ATOS

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 15.00 times fewer shares (a 1:15 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Atossa Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2026-02-021:15Yes$0.37$0.02
2018-04-201:12Yes$0.29$0.02
2016-08-261:15Yes$0.20$0.01

About Atossa Therapeutics, Inc.

Company overview and industry information

Atossa Therapeutics, Inc. (ATOS) operates in the Biotechnology industry. The recent 1-for-15 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Atossa Therapeutics, Inc. Summary

Last updated: 7/21/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.